J. Bajgar
University of Defence
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J. Bajgar.
Chemico-Biological Interactions | 2008
Daniel Jun; Lucie Musilova; Kamil Kuca; Jiri Kassa; J. Bajgar
Organophosphorus pesticides (e.g. chlorpyrifos, malathion, and parathion) and nerve agents (sarin, tabun, and VX) are highly toxic organophosphorus compounds with strong inhibition potency against two key enzymes in the human body-acetylcholinesterase (AChE; EC 3.1.1.7) and butyrylcholinesterase (BuChE; EC 3.1.1.8). Subsequent accumulation of acetylcholine at synaptic clefts can result in cholinergic crisis and possible death of intoxicated organism. For the recovery of inhibited AChE, derivatives from the group of pyridinium or bispyridinium aldoximes (called oximes) are used. Their efficacy depends on their chemical structure and also type of organophosphorus inhibitor. In this study, we have tested potency of selected cholinesterase reactivators (pralidoxime, obidoxime, trimedoxime, methoxime and H-oxime HI-6) to reactivate human erythrocyte AChE and human plasma BuChE inhibited by pesticide paraoxon. For this purpose, modified Ellmans method was used and two different concentrations of oximes (10 and 100 microM), attainable in the plasma within antidotal treatment of pesticide intoxication were tested. Results demonstrated that obidoxime (96.8%) and trimedoxime (86%) only reached sufficient reactivation efficacy in case of paraoxon-inhibited AChE. Other oximes evaluated did not surpassed more than 25% of reactivation. In the case of BuChE reactivation, none of tested oximes surpassed 12.5% of reactivation. The highest reactivation efficacy was achieved for trimedoxime (12.4%) at the concentration 100 microM. From the data obtained, it is clear that only two from currently available oximes (obidoxime and trimedoxime) are good reactivators of paraoxon-inhibited AChE. In the case of BuChE, none of these reactivators could be used for its reactivation.
Acta Medica (Hradec Kralove, Czech Republic) | 2010
J. Bajgar
The studies dealing with mechanism of organophosphates (OP)/nerve agent action, prophylaxis and treatment of intoxications is a very hot topic at present. Though the research is very intensive, unfortunately, up to now, there is not universal or significantly better reactivator sufficiently effective against all nerve agents/OP when compared with presently available oximes (pralidoxime, methoxime, obidoxime, trimedoxime, HI-6). The use of the most effective reactivator (HI-6) using simple type of autoinjector (e.g. ComboPen) is strictly limited because of decomposition of HI-6 in solution. Thanks to better solubility it is clear that another salt of HI-6 (dimethanesulfonate, HI-6 DMS) is more convenient for the use as antidote against nerve agents in the autoinjector than HI-6 chloride (Cl). It was clearly demonstrated that reactivation potency of HI-6 DMS in comparison with HI-6 Cl in vivo was the same and bioavailability of HI-6 DMS is better than that of HI-6 Cl. Three chambered autoinjector allows administration of all three antidotes (atropine, reactivator, diazepam) simultaneously. Moreover, the content of chambers can be changed according to proposed requirements. Possible way to solve the problem of universal reactivator could be the use of two reactivators. Three chambered autoinjector is an ideal device for this purpose.
Mini-reviews in Medicinal Chemistry | 2012
Jiri Kassa; Kamil Musilek; J. Zdarova Karasova; Kamil Kuca; J. Bajgar
Highly toxic organophosphorus inhibitors of acetylcholinesterase referred as nerve agents are considered to be among the most dangerous chemical warfare agents. The oximes represent very important part of medical countermeasures of nerve agent poisonings. They are used to reactivate the nerve agent-inhibited acetylcholinesterase. Despite long-term research activities, there is no single, broad-spectrum oxime suitable for the antidotal treatment of poisoning with all organophosphorus agents. There are two approaches how to increase and broaden the effectiveness of antidotal treatment of poisoning with nerve agents - to develop new structural analogues of currently available oximes and/or to combine currently available or newly developed oximes. The review describes the evaluation of the potency of newly developed oximes (especially the oxime K203) or combinations of oximes to reactivate nerve agent-inhibited acetylcholinesterase and to counteract the acute toxicity of nerve agents in comparison with single commonly used oxime (obidoxime, trimedoxime or HI-6).
Letters in Drug Design & Discovery | 2005
Kamil Kuca; J. Cabal; J. Bajgar; Daniel Jun
Abstract: Organophosphorus compounds, especially nerve agents, inhibit enzyme acetylcholinesterase(AChE; EC 3.1.1.7) in an irreversible manner. Atropine plus an oxime reactivator are used as an effectivetreatment of organophosphate poisoning. In this work, we have evaluated reactivation potency of twentyreactivators of different chemical structures in reactivation of VX-inhibited AChE. Rat brain AChE homogenatewas used as the appropriate source of the enzyme. According to our results, trimedoxime seems to be the mostpotent reactivator of VX-inhibited AChE at the concentration 10 -3 M. Keywords: Nerve agent, reactivation, inhibition, acetylcholinesterase, trimedoxime, oxime, VX agent. INTRODUCTION organophosphate poisoning. Oxime reactivators break thebond between enzyme and organophosphate and restore thefunctional enzyme (Scheme 1 – Reactivation). However,none from the currently used AChE reactivators is able tosatisfactorily reactivate AChE inhibited by all kinds of OPs[2a].Organophosphorus compounds (OPs) have been widelyused as pesticides in many parts of the world and have beenalso misused as chemical warfare agents [1]. From thisgroup, nerve agents are the most known [2]. In the past, theywere also used in terroristic attack in Tokyo subway [3].Therefore, the threat of the intoxication with OPs isrelatively high. The most potent nerve agents are representedMany laboratories over the world are interested in thesynthesis of the so-called “broad spectrum” reactivator that
Acta Medica (Hradec Kralove, Czech Republic) | 2012
Jiří Kassa; Jana Zdarova Karasova; Růžena Pavlíková; Filip Caisberger; J. Bajgar
The reactivating and therapeutic efficacy of two combinations ofoximes (HI-6 + trimedoxime and HI-6 + K203) was compared with the effectiveness of antidotal treatment involving single oxime (HI-6, trimedoxime, K203) using in vivo methods. In vivo determined percentage of reactivation of cyclosarin-inhibited blood and tissue acetylcholinesterase in poisoned rats showed that the reactivating efficacy of both combinations of oximes is slightly higher than the reactivating efficacy of the most effective individual oxime in blood, diaphragm as well as in brain. Moreover, both combinations of oximes were found to be slightly more efficacious in the reduction of acute lethal toxic effects in cyclosarin-poisoned mice than the antidotal treatment involving single oxime. Based on the obtained data, we can conclude that the antidotal treatment involving chosen combinations of oximes brings a beneficial effect for its ability to counteract the acute poisoning with cyclosarin.
Acta Medica (Hradec Kralove, Czech Republic) | 2008
J. Bajgar
The protective effect of the reversible cholinesterase inhibitors tacrine and pyridostigmine alone or in combination with different drugs against acetylcholinesterase inhibition in the pontomedullar area and cerebellum of rats caused by VX agent (O-ethyl S-2-diisopropylaminoethyl methyl phosphonothiolate) in vivo (2xLD50) was studied along with survival of animals pretreated with different combinations of the drugs used. The best prophylactic effect was observed in a combination of pyridostigmine with benactyzine, trihexyphenidyle and HI-6. Tacrine alone or in other combinations has had no better prophylactic effect in comparison with these combinations containing pyridostigmine. Equine butyrylcholinesterase, also protected against VX poisoning very effectively.
Journal of Applied Toxicology | 2007
J. Bajgar; Kamil Kuca; Josef Fusek; Jana Žďárová Karasová; Jiri Kassa; J. Cabal; Daniel Jun; Vaclav Blaha
Archives of Toxicology | 1983
J. Bajgar; Josef Fusek; Jiří Patočka; Vratislav Hrdina
Toxicology Letters | 2011
Jiri Kassa; J. Zdarova Karasova; Vendula Sepsova; G. Kunesova; Filip Caisberger; Miroslav Pohanka; J. Bajgar
Fuel and Energy Abstracts | 2011
J. Bajgar; Jiri Kassa; Miroslav Pohanka